|
|
| Phases of Development | Preclinical | Phase I | Phase II | Phase II/III | Phase III | Registration | Marketed |
|---|
| Autoimmune | 0 | 0 | 0 | 0 | 1 | 1 | 3 | | Cancer | 1 | 0 | 2 | 1 | 0 | 0 | 0 | | Dermatology | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Endocrine / Metabolic | 0 | 0 | 1 | 0 | 0 | 0 | 1 | | Gastrointestinal | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Inflammation | 0 | 0 | 1 | 0 | 0 | 1 | 1 | | Neurology | 0 | 1 | 2 | 0 | 0 | 0 | 4 |
|
|
Products Targeting Cyclooxygenase-2 (COX-2)